Related Experiment Video
Updated: May 1, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation
Elisa Longhi1, Andrea Magni2, Luca Torielli2
1Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Stezzano 87, Bergamo 24126, Italy.
Researchers developed a new strategy targeting client proteins to disrupt Heat Shock Protein 90 (HSP90) function, offering a promising approach for cancer therapy by avoiding common inhibitor side effects.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Heat Shock Protein 90 (HSP90) is crucial for protein folding and activation, making it a cancer target.
- Current HSP90 inhibitors face limitations due to broad client depletion and protective heat shock responses.
Purpose of the Study:
- To develop a client-directed strategy to modulate HSP90 activity by targeting unstable client protein regions.
- To design peptide mimics that compete with chaperone engagement for HSP90 clients.
Main Methods:
- Computational energy-decomposition analysis of the glucocorticoid receptor (GR) ligand-binding domain.
- Identification and design of GR-derived peptide mimics.
- In vitro binding assays with purified HSP90 and cell-based assays in triple-negative breast cancer cells.
Main Results:
- Identified unstable substructures in GR that sample unfolded conformations.
- Developed cell-permeable GR peptide mimics that selectively bind HSP90.
- Demonstrated that these peptides induce GR degradation and potentiate anti-cancer drug response.
Conclusions:
- A novel framework integrating computational analysis and rational design of client-derived peptides to modulate HSP90-dependent pathways.
- This approach offers a therapeutic strategy by targeting weak, client-specific interactions within proteostasis networks.
- Highlights potential for developing new cancer therapeutics by targeting chaperone-client interactions.
Related Concept Videos
GPCR Desensitization
Desensitization and Tachyphylaxis
GPCRs Regulate Adenylyl Cylase Activity
Cushing Syndrome II: Pathophysiology
Hypothalamic-Pituitary Axis
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

